Development of a treatment selection algorithm for SGLT2 and DPP-4 inhibitor therapies in people with type 2 diabetes: a retrospective cohort study. (2022)
Attributed to:
MICA: MRC APBI STratification and Extreme Response Mechanism IN Diabetes - MASTERMIND
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s2589-7500(22)00174-1
PubMed Identifier: 36427949
Publication URI: http://europepmc.org/abstract/MED/36427949
Type: Journal Article/Review
Volume: 4
Parent Publication: The Lancet. Digital health
Issue: 12
ISSN: 2589-7500